Research Volunteers Needed for New Studies
- Please call our Memory Study Line at 801-587-7888 for more information or to sign up.
- We need volunteers with memory problems as well as healthy volunteers, who may be included in a study's control group.
- If you or someone you care about is interested in helping us learn more about memory problems, our team can answer any questions you may have about clinical research studies or currently available research opportunities.
Studies Currently Enrolling
- Solaneuzumab in Mild Alzheimer's Disease:
A Phase 3, placebo-controlled study in mild Alzheimer's disease (AD) patients designed to collect data on long term safety and effectiveness of solanezumab, including cognitive outcomes, functional outcomes, quality of life, resource utilization, and biomarker measurements. Patients should be between the ages of 55 and 90, have been diagnosed with mild AD, not have had any infectious brain disease or cancer within the past five years. For more information, please contact us at 801-587-7888.
At the Forefront of Alzheimer's and Dementia Research
One of the Center's major goals is conducting research to better understand the causes of Alzheimer's disease and related memory disorders. Research at CACIR focuses on neuroimaging, clinical trials to examine the effectiveness of new drugs and treatments, and studies that examine the clinical features and pathophysiology of Alzheimer's and related memory disorders.
The Center sets itself apart from other Alzheimer's programs nationwide by implementing its research successes in the Cognitive Disorders Clinic. "We have an opportunity to develop innovative approaches to dementia care," Dr. Foster says. "I am convinced that now is the time to do this." By creating synergy between patient care and clinical research, the Center hopes to improve the standard of dementia care throughout the Intermountain West.
Using advanced imaging techniques and Utah's unique genetics resources, Foster and his colleagues are working to illuminate how specific changes in the brain correlate with differences in patient behavior. They also have shown how neuroimaging can help differentiate between Alzheimer's disease and other causes of dementia, such as frontotemporal dementia — knowledge that can help experts diagnose the cause of dementia more accurately and at earlier stages, when treatments are most effective. To learn more about neuroimaging at CACIR, click here.
Learn More About Research
Another major goal of the Center is promoting awareness about Alzheimer's and the importance of research. For useful information from the U.S. Food and Drug Administration about participating in clinical trials, click here.
Click here to search for clinical Alzheimer's trials that are currently recruiting in Utah. This will take you to ClinicalTrials.gov, a federal registry that contains information about ALL trials being conducted in the U.S. and abroad, including information about who can participate, locations, and who to contact if you'd like to participate.
To learn more about the University of Utah Alzheimer's Center, and view educational materials such as brochures and posters, please visit our Publications Gallery. To view recent scientific publications by Center faculty members, please click on the links below: